Fact CheckerSign in

NCT06729463Completed

IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients

IKBKB Gene Polymorphism (Single Nucleotide Polymorphism) (SNP) in Psoriatic and Psoriatic Arthritis Patients and Its Relation With Response to Systemic Biologic Therapy

Source: ClinicalTrials.gov · Last updated 14 Aug 2025

Brief summary (registry, in English)

Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. It impairs patients' quality of life enormously. Psoriasis refers to a persistent inflammatory illness of the skin and joints. It also impacts roughly 2%-3% of the inhabitants of the universe

Status (registry)
Completed
Study type
Interventional
Enrollment
50 (actual)
First submitted
4 Dec 2024
Start date
1 Dec 2024
Primary completion date
1 Mar 2025
Lead sponsor
South Valley University
NCT number
NCT06729463

What you commit to

  • Study type: Interventional
  • Participants enrolled: 50
  • From 1 Dec 2024 to the primary completion date, 1 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient receiving immune suppressive drugs.

Other illness

  • Patients having malignancy.
  • Patients having liver disease ( Hepatitis)
  • Patients having comorbid and/or uncontrolled renal, cardiac, vascular, and hepatic diseases or symptoms.
  • Active infection or human immunodeficiency virus (HIV)
  • Tuberculosis

Other

  • Pregnant or lactating female.

Who the study is looking for

  • Patients between the ages of 16 and 60 years proved having psoriasis diagnosed clinically for at least 6 months and who have a severity grade of moderate to severe, defined as a Psoriasis Area and Severity Index (PASI) score greater than 10, and involvement of greater than 10% of the body surface area (BSA) with or without psoriatic arthritis

Age in the registry: 16 years to 60 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
South Valley Hospitals
Coordinator of this site? Confirm its status
QinaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.